| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100158955 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity |
| 06/24/2010 | US20100158948 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| 06/24/2010 | US20100158947 Permissive cells and uses thereof |
| 06/24/2010 | US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 06/24/2010 | US20100158939 Vaccine against pandemic strains of influenza viruses |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158926 Antibodies to erbb2 |
| 06/24/2010 | US20100158920 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158917 Methods for diagnosing cancer and decreasing metastasis by cancer cells |
| 06/24/2010 | US20100158913 Antibody Molecules Having Specificity for Human IL-1B |
| 06/24/2010 | US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158891 Human Coagulation Factor VII Variants |
| 06/24/2010 | US20100158886 Triple acting antimicrobials that are refractory to resistance development |
| 06/24/2010 | US20100158879 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 06/24/2010 | US20100158868 Use of Fetal Cells for the Treatment of Genetic Diseases |
| 06/24/2010 | US20100158867 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100154293 Methods and compositions related to thioesterase enzymes |
| 06/24/2010 | DE102008063606A1 New nucleic acid construct, comprising first and second expression cassette comprising operatively linked e.g. constitutive expressing promoter, and minimal promoter, respectively, useful to prepare a product e.g. polypeptide or ribozyme |
| 06/24/2010 | DE102008063003A1 Nukleinsäureaufreinigungsverfahren Nucleic acid purification method |
| 06/24/2010 | DE102008063001A1 Nukleinsäureaufreinigungsverfahren Nucleic acid purification method |
| 06/24/2010 | DE102004062386B4 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 06/24/2010 | CA2747678A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 06/24/2010 | CA2747552A1 A plant with altered inflorescence |
| 06/24/2010 | CA2747535A1 Method for assembly of polynucleic acid sequences |
| 06/24/2010 | CA2747534A1 Non-human transgenic animals expressing humanised antibodies and use therof |
| 06/24/2010 | CA2747120A1 Methods of modulating the sex of avians |
| 06/24/2010 | CA2746952A1 Microorganisms and methods for conversion of syngas and other carbon sources to useful products |
| 06/24/2010 | CA2746840A1 Yeast display systems |
| 06/24/2010 | CA2746796A1 Method for speeding up plant growth and improving yield by introducing phosphatases in transgenic plant |
| 06/24/2010 | CA2746340A1 Pcv 2-based methods and compositions for the treatment of pigs |
| 06/24/2010 | CA2746310A1 Methods and compositions for use of a coccidiosis vaccine |
| 06/24/2010 | CA2745747A1 Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same |
| 06/24/2010 | CA2744310A1 Bidirectional promoter from z. mais |
| 06/24/2010 | CA2706317A1 Doc1 compositions and methods for treating cancer |
| 06/23/2010 | EP2199407A1 In vitro methods and compositions for the diagnosis and/or treatment of adenocarcinoma |
| 06/23/2010 | EP2199406A1 Intraoperative lymph node assay |
| 06/23/2010 | EP2199405A2 Polypeptides substrates of LRRK2 and uses thereof |
| 06/23/2010 | EP2199400A1 Single recombination system and methods of use |
| 06/23/2010 | EP2199399A1 Production of ketocarotenoids in plants |
| 06/23/2010 | EP2199398A1 Plants having enhanced yield-related traits and a method for making the same |
| 06/23/2010 | EP2199397A2 Plants having modified growth characteristics and a method for making the same |
| 06/23/2010 | EP2199396A1 Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same |
| 06/23/2010 | EP2199395A1 Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same |
| 06/23/2010 | EP2199394A1 Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same |
| 06/23/2010 | EP2199393A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 06/23/2010 | EP2199392A2 Genetic modification of somatic cells and uses thereof |
| 06/23/2010 | EP2199391A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 06/23/2010 | EP2199390A1 Anti-epha2 antibody |
| 06/23/2010 | EP2199389A1 Mutant AOX1 promoters |
| 06/23/2010 | EP2199388A1 Udp-glucuronyl transferase and polynucleotide encoding the same |
| 06/23/2010 | EP2199378A1 A method of designing alpha-amylase mutants with predetermined properties |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199298A1 Sirna silencing of Apolipoprotein B |
| 06/23/2010 | EP2198891A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 06/23/2010 | EP2198882A2 Nucleic acid mucosal immunization |
| 06/23/2010 | EP2198879A1 CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| 06/23/2010 | EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 06/23/2010 | EP2198700A1 Method for the production of a transgene-free plant with altered methylation pattern |
| 06/23/2010 | EP2198041A1 Method and composition for cancer diagnosis and treatment |
| 06/23/2010 | EP2198032A2 Magnetic delivery device |
| 06/23/2010 | EP2198030A2 Synthetic genes encoding cry1ac |
| 06/23/2010 | EP2198029A1 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 06/23/2010 | EP2198028A2 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
| 06/23/2010 | EP2198027A1 Short polypeptide mediated conformational changes promoting enhancement of enzymatic activity |
| 06/23/2010 | EP2198025A1 Generation of human embryonic stem-like cells using intronic rna |
| 06/23/2010 | EP2198024A2 Rna antagonist compounds for the modulation of fabp4/ap2 |
| 06/23/2010 | EP2198023A1 Method for identifying the interaction partner of an active agent |
| 06/23/2010 | EP2198022A1 Designed armadillo repeat proteins |
| 06/23/2010 | EP2198021A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2010 | EP2198016A1 Porcine adeno-associated viruses |
| 06/23/2010 | EP2198005A1 Peroxisome biogenesis factor protein (pex) disruptions for altering the content of polyunsaturated fatty acids and the total lipid content in oleaginous eukaryotic organisms |
| 06/23/2010 | EP2197909A2 Receptor-targeting reagents |
| 06/23/2010 | EP2197906A1 Fusion polypeptide comprising s-antigen repeat units |
| 06/23/2010 | EP2197903A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity |
| 06/23/2010 | EP2197894A1 Degenerate oligonucleotides and their uses |
| 06/23/2010 | EP2197497A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 06/23/2010 | EP2197496A2 Sam-ii riboswitch and uses thereof |
| 06/23/2010 | EP2197495A2 Lipopeptides for delivery of nucleic acids |
| 06/23/2010 | EP2197488A1 Immune stimulatory oligonucleotide analogs containing modified sugar moieties |
| 06/23/2010 | EP1670309B1 Transgenic animals with serious disorders related to alzheimer's disease |
| 06/23/2010 | EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 06/23/2010 | EP1246945B1 Method for identifying a mark applied on a solid body |
| 06/23/2010 | EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 06/23/2010 | EP0948628B1 Method for the production of glycerol by recombinant organisms |
| 06/23/2010 | EP0790835B2 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 06/23/2010 | CN201512539U Quick DNA extraction and storage kit based on silica gel film |
| 06/23/2010 | CN201512535U Blade PCR fast sampling device |
| 06/23/2010 | CN1995362B Gibberella fujikuroi electroporation genetic transformation method |
| 06/23/2010 | CN1906304B Plants having increased yield and method for making the same |
| 06/23/2010 | CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 06/23/2010 | CN1876819B Genetically engineered duckweed |
| 06/23/2010 | CN1871351B Novel fungal proteins and nucleic acids encoding same |
| 06/23/2010 | CN1871256B Muteins of tear lipocalin |
| 06/23/2010 | CN1845993B Interfering RNA duplex having blunt-ends and 3'-modifications |